Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn how best to treat substance use disorders in an HIV
clinic setting. Specifically, the purpose of this pilot study is to learn if extended-release
naltrexone (XR-NTX) would be a feasible and acceptable treatment for HIV-infected individuals
with opioid or alcohol use disorders.